The prefilled syringe presentation of Shingrix does not require reconstitution.

PHILADELPHIA, July 17, 2025--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

(Alliance News) - GSK PLC on Thursday said the prefilled syringe version of its vaccine Shingrix has been approved for use in the US for the prevention of shingles. The London-based drug maker ...

The prefilled syringe presentation of GSK’s shingles vaccine is also undergoing regulatory review by the European Medicines Agency (EMA), with filing acceptance received in January 2025, marking ...

The prefilled syringe presentation of GSK’s shingles vaccine is also undergoing regulatory review by the European Medicines Agency (EMA), with filing acceptance received in January 2025, marking ...

PHILADELPHIA, July 17, 2025--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine ...

FDA approves Shingrix prefilled syringe: New format eliminates reconstitution step, simplifying shingles (herpes zoster) vaccine administration for healthcare providers. Same indications, easier ...

The company added that the prefilled syringe presentation of GSK's shingles vaccine is also undergoing regulatory review by the European Medicines Agency.

GSK received Food and Drug Administration approval for a prefilled syringe presentation of Singrix, a prevention vaccine for shingles. The syringe removes the need to reconstitute separate vials ...